Physician profile
Brooke Hall
NPI 1730665597
$2,342.14
in general payments reported to CMS, 2019-2025
19 companies · $665 in 2025
The $665 reported for 2025 was more than what 78% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $66.64 · 2022: $308 · 2023: $458 · 2024: $844 · 2025: $665.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,927 · Education: $40.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,926.66 |
| Education | $40.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $430.69 | 2022-2025 | Farxiga, Airsupra, Breztri |
| Novo Nordisk INC | $384.92 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $345.91 | 2021-2025 | |
| Glaxosmithkline, LLC. | $239.66 | 2021-2025 | Trelegy Ellipta, Shingrix, Penmenvy |
| Lilly USA, LLC | $194.48 | 2022-2025 | Mounjaro, Zepbound |
| Bayer Healthcare Pharmaceuticals INC. | $178.85 | 2023-2025 | |
| Amgen INC. | $126.99 | 2022-2025 | Otezla, Repatha, Otezla |
| Novartis Pharmaceuticals Corporation | $103.89 | 2023-2025 | |
| Exact Sciences Corporation | $98.57 | 2023-2025 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $54.14 | 2023 | Jardiance |
| Dexcom, INC. | $38.94 | 2023 | Dexcom G6 Transmitter |
| Phathom Pharmaceuticals, INC. | $28.28 | 2025 | Voquezna |
| Mylan Specialty L.P. | $21.65 | 2023 | Yupelri |
| Takeda Pharmaceuticals U.S.A., INC. | $19.35 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $18.37 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $17.83 | 2022 | |
| Amneal Pharmaceuticals LLC | $15.66 | 2023 | Unithroid |
| Organon LLC | $11.99 | 2024 | |
| Merck Sharp & Dohme LLC | $11.97 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brooke Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.